Correlation Engine 2.0
Clear Search sequence regions


  • chimera (5)
  • DC50 (3)
  • Dmax (1)
  • proteolysis (6)
  • Sizes of these terms reflect their relevance to your search.

    A proteolysis-targeting chimera (PROTAC) is a new technology that marks proteins for degradation in a highly specific manner. During screening, PROTAC compounds are tested in concentration-response (CR) assays to determine their potency, and parameters such as the half-maximal degradation concentration (DC50) are estimated from the fitted CR curves. These parameters are used to rank compounds, with lower DC50 values indicating greater potency. However, PROTAC data often exhibit biphasic and polyphasic relationships, making standard sigmoidal CR models inappropriate. A common solution includes manual omitting of points (the so-called masking step), allowing standard models to be used on the reduced data sets. Due to its manual and subjective nature, masking becomes a costly and nonreproducible procedure. We therefore used a Bayesian changepoint Gaussian processes model that can flexibly fit both nonsigmoidal and sigmoidal CR curves without user input. Parameters such as the DC50, maximum effect Dmax, and point of departure (PoD) are estimated from the fitted curves. We then rank compounds based on one or more parameters and propagate the parameter uncertainty into the rankings, enabling us to confidently state if one compound is better than another. Hence, we used a flexible and automated procedure for PROTAC screening experiments. By minimizing subjective decisions, our approach reduces time and cost and ensures reproducibility of the compound-ranking procedure. The code and data are provided on GitHub (https://github.com/elizavetasemenova/gp_concentration_response).

    Citation

    Elizaveta Semenova, Maria Luisa Guerriero, Bairu Zhang, Andreas Hock, Philip Hopcroft, Ganesh Kadamur, Avid M Afzal, Stanley E Lazic. Flexible Fitting of PROTAC Concentration-Response Curves with Changepoint Gaussian Processes. SLAS discovery : advancing life sciences R & D. 2021 Oct;26(9):1212-1224

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34543136

    View Full Text